Home Newsfeeds Barclays Upgrades Helmerich & Payne to Overweight

Barclays Upgrades Helmerich & Payne to Overweight

Barclays analyst David Anderson upgrades Helmerich & Payne (NYSE:HP) from Equal-Weight to Overweight.

byBenzinga Newsdesk

July 14, 2022

1 minute read

Barclays analyst David Anderson upgrades Helmerich & Payne (NYSE:HP) from Equal-Weight to Overweight.

Entrada Therapeutics Q3 EPS $(0.80) Up From $(9.78) YoY

By Benzinga Newsdesk

November 7, 8:13 AM

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.80) per share. This is a 91.82 percent increase over losses of $(9.78) per share from the same period last year.

TRDA

News

‘Roku Introduces New Platform Features, Further Personalizing The Streaming Experience’

By Benzinga Newsdesk

October 4, 9:09 AM

https://newsroom.roku.com/news/2023/10/roku-introduces-new-platform-features-further-personalizing-the-streaming/ufyv0dnl-1696350406Roku, Inc. (NASDAQ:ROKU), the # 1 TV streaming platform in the U.S.1, announced new

ROKU

Why Entrada Therapeutics Shares Are Trading Lower By 32%; Here Are 31 Stocks Moving Premarket

By Lisa Levin

December 20, 7:13 AM

Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares rose 158% to $2.42 in pre-market trading after the company announced interim results from the ICESECRET study for the treatment of patients with small renal masses who cannot be offered kidney-preserving surgery.

ADXN